HemoShear Therapeutics is Drug Discovery in United States that focus on development programs business. Founded in 2008. They cover business area such as developer, novel drug treatment, life, patient, rare metabolic disease, people, rare metabolic defect, basic biochemical process, healthcare organization, their drug discovery, development program, liver disease, gout, metabolic disorder.
2008
( 18 years old in 2026 )
Development Programs
-
501 Locust Avenue
Suite 301
Charlottesville, VA 22902
United States
Private
developernovel drug treatmentlifepatientrare metabolic diseasepeoplerare metabolic defectbasic biochemical processhealthcare organizationtheir drug discoverydevelopment programliver diseasegoutmetabolic disorder
* We use standard office opening hours in near HemoShear Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
HemoShear Therapeutics is Drug Discovery business from United States that founded in 2008 (18 years old in 2026), HemoShear Therapeutics business is focusing on Development Programs.
HemoShear Therapeutics headquarter office and corporate office address is located in 501 Locust Avenue Suite 301 Charlottesville, VA 22902 United States.
HemoShear Therapeutics was founded in United States.
In 2026, HemoShear Therapeutics is currently focus on development programs sector.
Above is snippet of Google Trends for "development programs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with HemoShear Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
